Robert J Bertolini's Net Worth
$12.1 Million
Who is Robert J Bertolini?
Robert J Bertolini has an estimated net worth of $12.1 Million. This is based on reported shares across multiple companies, which include BRISTOL MYERS SQUIBB CO, GENZYME CORP, Merck & Co., Inc., and CHARLES RIVER LABORATORIES INTERNATIONAL, INC..
SEC CIK
Robert J Bertolini's CIK is 0001270263
Past Insider Trading and Trends
2020 was Robert J Bertolini's most active year for acquiring shares with 11 total transactions. Robert J Bertolini's most active month to acquire stocks was the month of April. 2018 was Robert J Bertolini's most active year for disposing of shares, totalling 91 transactions. Robert J Bertolini's most active month to dispose stocks was the month of December. 2009 saw Robert J Bertolini paying a total of $1,485,997.67 for 379,303 shares, this is the most they've acquired in one year. In 2020 Robert J Bertolini cashed out on 21,400 shares for a total of $1,838,081.72, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
BRISTOL MYERS SQUIBB CO (BMY) Snapshot price: $48.665
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 30
| |||
Form 4
| +2,770.78% | 11K |
$44.72 | $491,920.00 | 11.4K |
Jul 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 21
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
GENZYME CORP No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -2.38K |
$74.00 | -$351,500.00 |
0
|
Apr 4
| |||
Form 4
|
∞
| 2.38K |
—
|
—
| 2.38K |
Jun 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Merck & Co., Inc. (MRK) Snapshot price: $127.6
Executive Vice President
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -110.72K |
—
|
—
|
0
|
Nov 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 1
| |||
Form 4
| +25.81% | 21.46K |
$23.70 | -$439,398.00 | 104.62K |
Apr 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 1
| |||
Form 4
| +40.91% | 24.14K |
$18.64 | -$388,793.12 | 83.16K |
Apr 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 1
| |||
Form 4
| +69.23% | 24.14K |
$21.93 | -$457,415.94 | 59.01K |
Dec 1
| |||
Form 4
|
∞
| 34.87K |
$21.98 | -$662,213.44 | 34.87K |
Nov 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 19
| |||
Form 4
|
∞
| 5.85K |
$19.60 | $114,718.21 | 5.85K |
Nov 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) Snapshot price: $219.245
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +3.69% | 1.13K |
—
|
—
| 31.85K |
May 15
| |||
Form 4
| +3.30% | 980 |
—
|
—
| 30.72K |
May 11
| |||
Form 4
| +2.07% | 603 |
—
|
—
| 29.74K |
May 7
| |||
Form 4
|
—
|
0
|
$113.44 | -$431,679.11 | 29.13K |
May 20
| |||
Form 4
| +4.52% | 1.26K |
—
|
—
| 29.13K |
May 11
| |||
Form 4
|
—
|
0
|
$112.79 | -$826,246.61 | 27.88K |
Feb 13
| |||
Form 4
| +10.02% | 2.54K |
—
|
—
| 27.88K |
May 22
| |||
Form 4
| -4.16% | -1.10K |
$134.71 | -$148,179.00 | 25.34K |
Dec 4
| |||
Form 4
| +4.34% | 1.1K |
$83.85 | -$306,112.27 | 26.44K |
Dec 4
| |||
Form 4
| +12.18% | 2.75K |
—
|
—
| 25.34K |
May 14
| |||
Form 4
| -13.78% | -3.61K |
$110.22 | -$397,784.52 | 22.59K |
Scheduled
|
Jan 2
| ||
Form 4
| +15.98% | 3.61K |
$74.93 | -$141,027.36 | 26.2K |
Scheduled
|
Jan 2
| ||
Form 4
| +12.09% | 2.44K |
—
|
—
| 22.59K |
May 12
| |||
Form 4
| -25.05% | -6.74K |
$88.00 | -$592,701.71 | 20.15K |
Mar 1
| |||
Form 4
| +33.42% | 6.74K |
$62.67 | -$6,646.20 | 26.89K |
Mar 1
| |||
Form 4
| +12.63% | 2.26K |
—
|
—
| 20.15K |
May 12
| |||
Form 4
| +12.37% | 1.97K |
—
|
—
| 17.89K |
May 6
| |||
Form 4
| +20.61% | 2.72K |
—
|
—
| 15.92K |
May 7
| |||
Form 4
| +32.53% | 3.24K |
—
|
—
| 13.2K |
May 8
| |||
Form 4
| +68.24% | 4.04K |
—
|
—
| 9.96K |
May 9
| |||
Form 4
| +62.64% | 2.28K |
—
|
—
| 5.92K |
May 11
| |||
Form 4
|
∞
| 3.64K |
—
|
—
| 3.64K |
Feb 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||